Nanomaterials‐mediated glycolysis rewriting to potentiate tumor immunotherapy
BMEMat · 2026-06 · 4 (2)
DOI: 10.1002/bmm2.70048 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMEMat, online erschienen am 14.11.2025. Verfasst von Zilin Ma und 9 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Immunotherapy has emerged as a transformative paradigm in tumor therapy, but its clinical potential remains limited by the immunosuppressive tumor microenvironment driven by dysregulated tumor metabolism. Aerobic glycolysis, a hallmark of abnormal tumor metabolism, not only fuels tumor proliferation but also reshapes the tumor microenvironment through lactate accumulation, hypoxia, and competitive glucose consumption. Recent advances in nanomedicine offer innovative strategies to reprogram tumor glycolysis for enhanced immunotherapy, achieved through precision targeting of pivotal nodes of glycolysis pathways, including glucose transport, enzymatic activity, and lactate consumption. This review systematically summarizes cutting‐edge advances in glycolysis‐rewiring nanomedicines, emphasizing their mechanisms in reversing immunosuppression and reinvigorating antitumor immune responses. Challenges in clinical translation and future directions for designing multifunctional metabolic‐immune modulators are also critically discussed.
Förderung
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Ma, Z., Li, S., Yan, J., Wang, X., Zhao, W., Song, Y., Liu, D., Jiao, J., Duan, X., & Zhang, G. (2026). Nanomaterials‐mediated glycolysis rewriting to potentiate tumor immunotherapy. BMEMat, 4(2). https://doi.org/10.1002/bmm2.70048
Vancouver
Ma Z, Li S, Yan J, Wang X, Zhao W, Song Y, et al. Nanomaterials‐mediated glycolysis rewriting to potentiate tumor immunotherapy. BMEMat. 2026;4(2). doi:10.1002/bmm2.70048
BibTeX
@article{Ma2026,
author = {Ma, Zilin and Li, Songyan and Yan, Jie and Wang, Xuechun and Zhao, Wen and Song, Yunxuan and Liu, Dongdong and Jiao, Jianwei and Duan, Xiuying and Zhang, Guiqiang},
title = {Nanomaterials‐mediated glycolysis rewriting to potentiate tumor immunotherapy},
journal = {BMEMat},
year = {2026},
volume = {4},
number = {2},
doi = {10.1002/bmm2.70048}
}
EUVIMED